COVID-19 in Children
어린이의 코로나19
Review
[키워드] benefit
children
Comorbidity
COVID-19
Glucocorticoids
healthy children
Hospitalized
hypoxia
immunomodulators
impacted
include
Inflammatory
Intravenous immunoglobulin
manifestation
MIS-C
monoclonal antibody
pediatrics
progression
refractory
Remdesivir
respiratory compromise
risk
SARS-CoV-2
severe cases
severe disease
severe respiratory disease
supportive care
syndrome
[DOI] 10.1016/j.idc.2021.11.002 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.idc.2021.11.002 PMC 바로가기 [Article Type] Review